IRIS
CAGNACCI, Angelo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.391
AS - Asia 4.084
EU - Europa 2.629
SA - Sud America 524
AF - Africa 55
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 6
Totale 19.709
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.324
SG - Singapore 2.061
CN - Cina 815
UA - Ucraina 760
HK - Hong Kong 445
BR - Brasile 434
DE - Germania 392
SE - Svezia 354
TR - Turchia 245
RU - Federazione Russa 239
VN - Vietnam 223
FR - Francia 185
IT - Italia 179
IE - Irlanda 158
FI - Finlandia 115
GB - Regno Unito 94
IN - India 69
BD - Bangladesh 34
IQ - Iraq 32
JP - Giappone 30
AR - Argentina 28
MX - Messico 25
NL - Olanda 25
CA - Canada 24
VE - Venezuela 22
EU - Europa 20
KR - Corea 19
PL - Polonia 19
AT - Austria 18
BE - Belgio 16
CZ - Repubblica Ceca 15
CO - Colombia 14
PK - Pakistan 14
ES - Italia 13
RS - Serbia 13
ZA - Sudafrica 11
EC - Ecuador 10
PH - Filippine 10
ID - Indonesia 9
KE - Kenya 9
SA - Arabia Saudita 9
JO - Giordania 8
AE - Emirati Arabi Uniti 7
MA - Marocco 7
CL - Cile 6
EG - Egitto 6
NP - Nepal 6
UZ - Uzbekistan 6
AU - Australia 5
IL - Israele 5
TN - Tunisia 5
CR - Costa Rica 4
ET - Etiopia 4
PY - Paraguay 4
RO - Romania 4
AM - Armenia 3
BG - Bulgaria 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MD - Moldavia 3
MY - Malesia 3
OM - Oman 3
PE - Perù 3
PS - Palestinian Territory 3
TH - Thailandia 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
AZ - Azerbaigian 2
BH - Bahrain 2
DK - Danimarca 2
DZ - Algeria 2
GE - Georgia 2
HU - Ungheria 2
IM - Isola di Man 2
IR - Iran 2
JM - Giamaica 2
LT - Lituania 2
LV - Lettonia 2
LY - Libia 2
NO - Norvegia 2
SN - Senegal 2
SV - El Salvador 2
TG - Togo 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
CD - Congo 1
CG - Congo 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GT - Guatemala 1
KH - Cambogia 1
KW - Kuwait 1
LC - Santa Lucia 1
LK - Sri Lanka 1
ME - Montenegro 1
MK - Macedonia 1
Totale 19.696
Salva come PNG Salva come JPEG
Città #
Fairfield 1.776
Woodbridge 1.286
Ashburn 1.074
Singapore 1.029
Houston 893
Chandler 848
Seattle 726
Wilmington 635
Cambridge 604
Ann Arbor 572
Hong Kong 439
Beijing 395
Dearborn 395
Jacksonville 357
Boardman 243
Izmir 230
Dublin 158
Princeton 156
Lauterbourg 150
Los Angeles 144
Des Moines 129
Dallas 115
San Jose 107
San Diego 78
Chicago 67
Redondo Beach 65
New York 64
Buffalo 58
Ho Chi Minh City 58
Santa Clara 55
Dong Ket 45
Falls Church 42
Hanoi 41
Salt Lake City 41
Council Bluffs 39
São Paulo 39
Hefei 35
Udine 33
Helsinki 31
Saint Petersburg 30
Frankfurt am Main 29
Norwalk 29
Kunming 28
Ogden 27
The Dalles 27
Tokyo 27
Munich 26
Nanjing 25
Guangzhou 24
Milan 24
Orem 21
Phoenix 20
Grafing 17
Brussels 16
Chennai 16
Denver 16
Venezia 16
Brooklyn 15
Baghdad 14
Brno 13
Fuzhou 13
Tampa 13
Warsaw 13
Amsterdam 12
Belgrade 12
Düsseldorf 12
Mumbai 12
Nuremberg 12
San Francisco 12
Jinan 11
Nanchang 11
Redmond 11
Sterling 11
Stockholm 11
Curitiba 10
Da Nang 10
Rio de Janeiro 10
Zhengzhou 10
Elk Grove Village 9
Mexico City 9
Miami 9
Poplar 9
Sorocaba 9
Tappahannock 9
Toronto 9
Vienna 9
Chengdu 8
Haiphong 8
Hebei 8
Montreal 8
Perth 8
Rome 8
Turku 8
Brasília 7
Chongqing 7
Gwangju 7
Istanbul 7
Johannesburg 7
Nairobi 7
Paris 7
Totale 14.095
Salva come PNG Salva come JPEG
Nome #
Female sexuality and vaginal health across the menopausal age 395
Fetal growth at term and placental oxidative stress in a tissue micro-array model: a histological and immunohistochemistry study 339
Menopausal symptoms and risk factors for cardiovascular disease in postmenopause. 227
Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women? 197
Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. 188
Bleeding profile in users of an etonogestrel sub-dermal implant: Effects of anthropometric variables. An observational uncontrolled preliminary study in Italian population 184
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation 184
Association between pelvic organ prolapse and climacteric symptoms in postmenopausal women 184
Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures. 178
Regulation of the 24h body temperature rhythm of women in luteal phase: role of gonadal steroids and prostaglandins. 177
Association between urinary incontinence and climacteric symptoms in postmenopausal women 176
Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study. 175
Adenomyosis of the Extrapelvic Portion of the Round Ligament 175
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial 174
Massive Hemoperitoneum from Uterine Leiomyoma Associated with Diffuse Myometrial Venous Congestion 171
High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study. 161
Intermenstrual pelvic pain, quality of life and mood 161
Maternal age and the risk of adverse pregnancy outcomes: a retrospective cohort study 156
Administration of raloxifene does not influence 24-hour ambulatory blood pressure of postmenopausal women with osteopenia: a double-blind placebo-controlled study. 155
A comparison of the central effects of different progestins used in hormone replacement therapy 155
Chronic pelvic pain improvement: impact on quality of life and mood 155
Integrated Clinical Pathways in vaginal and caesarean delivery: effect analysis 2016-2017, Italy 155
Relation between body mass index and endothelium-dependent vasodilatation in healthy postmenopausal women. 154
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History 154
Prevalence of menstrual pain in young women: what is dysmenorrhea 151
Indirect evidence that estrogen replacement therapy stimulates nitric oxide synthase in postmenopausal women 148
Increased cortisol level: a possible link between climacteric symptoms and cardiovascular risk factors. 147
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 147
Influences of maternal weight on the secondary sex ratio of human offspring 147
Age at Menopause and Extent of Coronary Artery Disease Among Postmenopausal Women with Acute Coronary Syndromes 147
Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study. 146
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 146
Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception 146
[Evolution and future of contraception.] 145
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes 144
Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea 144
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 144
Role of melatonin in circadian rhythm at menopause 140
Folate administration decreases oxidative status and blood pressure in postmenopausal women 140
Different circulatory response to melatonin in postmenopausal women without and with hormone replacement therapy 140
Influence of transdermal estradiol in the regulation of leptin levels of postmenopausal women: a double-blind, placebo-controlled study. 138
Dienogest mediates midkine suppression in endometriosis 138
Acupuncture or phy(F)itoestrogens vs. (E)strogen plus progestin on menopausal symptoms. A randomized study 138
Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function. 137
Acute modifications in the levels of daytime melatonin do not influence leptin in postmenopausal women. 137
Influence of melatonin administration on glucose tolerance and insulin sensitivity of postmenopausal women 136
Counseling on vaginal delivery of contraceptive hormones: implications for women's body knowledge and sexual health 136
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women 135
Raloxifene does not influence flow-mediated endothelium-dependent and endothelium-independent vasodilatation of osteopenic postmenopausal women. 134
Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women 134
Course of primary headaches during hormone replacement therapy 133
Prolonged melatonin administration decreases nocturnal blood pressure in women. 132
Neutral effect of prolonged transdermal hormone therapy on liver function of postmenopausal women with chronic active hepatitis 132
Raloxifene does not modify insulin sensitivity and glucose metabolism in postmenopausal women. 131
Administration of tibolone decreases 24h heart rate but not blood pressure of post-menopausal women 131
Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study 131
Hormonal contraception: venous and arterial disease 131
Effect of exogenous melatonin on vascular reactivity and nitric oxide in postmenopausal women: role of hormone replacement therapy 131
History of vasomotor symptoms, extent of coronary artery disease, and clinical outcomes after acute coronary syndrome in postmenopausal women 131
Modification of blood pressure in postmenopausal women: role of hormone replacement therapy 130
European society of contraception statement on contraception in obese women 130
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group (.) 130
Sexual dimorphism in the levels of amniotic fluid leptin in pregnancies at 16 weeks of gestation 130
Impact of transvaginal hydrolaparoscopy ovarian drilling on ovarian stromal blood flow and ovarian volume in clomiphene citrate-resistant PCOS patients: a case-control study 130
Effects of low- or high-dose hormone therapy on fasting and post-methionine homocysteine levels in postmenopausal women 129
Effects of two different oral contraceptives on homocysteine metabolism in women with polycystic ovary syndrome 129
Intensity of menstrual pain and estimated angle of uterine flexion 129
Thoracic ultrasound evaluation and B-type natriuretic peptide value in elective cesarean section under spinal anesthesia 129
Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women. 128
Ospemifene in the management of vulvar and vaginal atrophy: Focus on the assessment of patient acceptability and ease of use 128
Management of vaginal atrophy: a real mess. Results from the AGATA study 127
Hormone replacement therapy and prevention of chronic conditions 127
Atypical polypoid adenomyoma follow-up and management: Systematic review of case reports and series and meta-analysis 127
The ovarian response to controlled stimulation in IVF cycles may be predictive of the age at menopause 125
Macro-regional variation in attitudes toward and experiences of vulvar and vaginal atrophy among Italian post-menopausal women: a post hoc analysis of REVIVE survey data 125
Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: Comparison between oral and transdermal administration of estrogen 124
Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis 124
Pharmacokinetic evaluation of desogestrel as a female contraceptive 124
ISPOG European Consensus Statement - chronic pelvic pain in women (short version) 124
Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol 123
Season of birth influences the timing of menopause 122
Reply to: Interactions BetweenMelatonin and Estrogen in the Regulation of Blood Pressure 122
Influence of exogenous melatonin on catecholamine levels in postmenopausal women prior and during oestradiol replacement 122
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 122
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: A prospective one-year evaluation 122
Metabolic impact of combined hormonal contraceptives containing estradiol 121
Insulin sensitivity in women: a comparison among values derived from intravenous glucose tolerance tests with different sampling frequency, oral glucose tolerance test or fasting 121
Vaginal atrophy across the menopausal age: results from the ANGEL study 121
Is voluntary abortion a seasonal disorder of mood? 120
Reproductive risk factors in women with family history of breast cancer attending an Italian Family Cancer Clinic 120
Impact of vulvovaginal atrophy of menopause: prevalence and symptoms in Italian women according to the EVES study 120
The most bothersome symptom of vaginal atrophy: Evidence from the observational AGATA study 119
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol 118
Relation between oxidative stress and climacteric symptoms in early postmenopausal women 118
Impact of laparoscopic cystectomy of endometriotic and non-endometriotic cysts on ovarian volume, antral follicle count (AFC) and ovarian doppler velocimetry 117
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. 116
Sympathoadrenal response of postmenopausal women prior and during prolonged administration of estradiol 115
Kava-Kava administration reduces anxiety in perimenopausal women. 115
Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel 115
Oral contraceptives and insulin sensitivity 114
Totale 14.450
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.783
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.783
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021545 0 0 0 0 0 0 0 0 0 92 268 185
2021/20221.368 92 101 124 93 33 96 98 54 29 210 231 207
2022/20231.930 181 104 19 256 211 587 6 140 276 24 63 63
2023/2024426 113 55 12 10 66 50 7 39 37 9 10 18
2024/20252.426 49 198 231 96 124 147 128 193 345 164 188 563
2025/20263.965 279 733 323 253 729 403 694 131 189 231 0 0
Totale 20.260